Guideline
Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update
Submitted: 12 December 2013 | Published: 04 June 2013
About the author(s)
The Southern African HIV Clinicians Society, SAHIVSOC, Johannesburg, South Africa, South AfricaAbstract
Six years after the first Society guidelines were published, cryptococcal meningitis (CM) remains an important cause of morbidity and mortality among HIV-infected adults in South Africa. Several important developments have spurred the publication of updated guidelines to manage this common fungal opportunistic infection. Recommendations described here include: (1) screening and pre-emptive treatment; (2) laboratory diagnosis and monitoring; (3) management of a first episode of CM; (4) amphotericin B deoxycholate toxicity prevention, monitoring and management; (5) timing of antiretroviral therapy among patients with CM; (6) management of raised intracranial pressure; (7) management of relapse episodes of CM.
Keywords
Metrics
Total abstract views: 8983Total article views: 23290
Crossref Citations
1. The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells
Adepemi O. Ogundeji, Nozethu Mjokane, Olufemi S. Folorunso, Carolina H. Pohl, Martin M. Nyaga, Olihile M. Sebolai
Pharmaceuticals vol: 14 issue: 5 first page: 404 year: 2021
doi: 10.3390/ph14050404